LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...
LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...
LVR-Klinikum Düsseldorf Hospital of the Heinrich-Heine University ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>LVR</strong>-KLINIKUM DÜsseLDORF – hOsPITaL OF The heINRIch-heINe UNIVeRsITY DÜsseLDORF<br />
Symptom<br />
60<br />
Project Network I<br />
Early Recognition<br />
and Early Intervention<br />
SN 1: Diagnostics and treatment <strong>of</strong> acute schizophrenia<br />
SN 2: Relapse prevention and long-term treatment<br />
SN 3: Prevention and rehabilitation <strong>of</strong> residual disease courses<br />
Project Network II<br />
Treatment and<br />
Rehabilitation<br />
1<br />
Subnetworks (SN)<br />
2 3<br />
Acute Long-term Rehabili -<br />
treatment treatment tation<br />
Manifestation threshold<br />
Figure 6: Research projects <strong>of</strong> <strong>the</strong> Competence Network on Schizophrenia (CNS) related to <strong>the</strong> course <strong>of</strong> schizophrenia<br />
s Transfer <strong>of</strong> <strong>the</strong> results <strong>of</strong> basic research into<br />
healthcare.<br />
s The cost/effectiveness analysis <strong>of</strong> innovative treatment<br />
procedures.<br />
s Improvement in educating and informing patients,<br />
relatives and (healthy) lay persons and experts through<br />
<strong>the</strong> targeted transfer <strong>of</strong> knowledge.<br />
The precondition for achieving <strong>the</strong>se goals is <strong>the</strong> creation,<br />
expansion and intensive and routine use <strong>of</strong> networked<br />
structures between research and care.<br />
The Structure and Themes <strong>of</strong> <strong>the</strong> Competence Network<br />
The Competence Network is organised, in accordance with<br />
<strong>the</strong> course <strong>of</strong> <strong>the</strong> disorder, into two essential project networks<br />
(PN), with several sub-networks (SN), focusing on treatment<br />
and care needs in <strong>the</strong> prodromal phase or initial episode (PN<br />
I) and after initial admission as an inpatient (PN II) (Figure<br />
5). Whereas PN I mainly deals with projects designed to<br />
improve and establish early diagnosis and early intervention,<br />
PN II is involved with projects for optimising acute and longterm<br />
treatment (SNs I+II), as well as for rehabilitation (SN<br />
III), in particular in residual schizophrenia. In addition, <strong>the</strong>re<br />
is a project network devoted to molecular genetics and<br />
several cross-discipline projects (such as health economics,<br />
educating <strong>the</strong> public, continuous medical education and<br />
post-graduate specialty training, etc.). In <strong>the</strong> third funding<br />
Disorder<br />
Course<br />
Time<br />
period, which has been running since 2005, in addition to four<br />
projects following up studies from <strong>the</strong> initial funding period<br />
specific so-called transfer projects were adopted relating<br />
to <strong>the</strong> core interests <strong>of</strong> <strong>the</strong> Competence Network, in which<br />
network results are prepared for transfer to <strong>the</strong> care sector.<br />
Partners involved in <strong>the</strong><br />
Competence Network across Germany<br />
Across Germany, <strong>the</strong> Competence Network on<br />
Schizophrenia involves a total <strong>of</strong> 19 university psychiatric<br />
departments, 14 state, district and specialist hospitals, and<br />
6 psychiatric and general medicine practice networks. The<br />
work <strong>of</strong> <strong>the</strong> Competence Network is supported by <strong>the</strong> World<br />
Psychiatric Association (WPA), German national specialist<br />
associations (such as <strong>the</strong> DGPPN representing psychiatrists<br />
and <strong>the</strong> DEGAM representing general practitioners) and<br />
pr<strong>of</strong>essional associations (such as <strong>the</strong> BVDN representing<br />
German <strong>of</strong>fice-based neurologists and psychiatrists), as well<br />
as <strong>the</strong> Central Association <strong>of</strong> Health Insurance Funds (GKV-<br />
Spitzenverband in German). In addition to <strong>the</strong> approximately<br />
16 million Euros <strong>of</strong> funding given by <strong>the</strong> FMER for <strong>the</strong> entire<br />
network and its over thirty projects since 1999, additional<br />
resources (around 5% <strong>of</strong> <strong>the</strong> budget) were made available by<br />
<strong>the</strong> pharmaceutical industry for research projects (Bristol-<br />
Meyers Squibb, Eli Lilly, Janssen-Cilag, Lundbeck, San<strong>of</strong>i-<br />
Syn<strong>the</strong>labo and Wyeth) or for educating <strong>the</strong> public (including